Literature DB >> 32010357

PORTABILITY OF GWAS RESULTS BETWEEN ETHNIC POPULATIONS: GENETIC MARKERS FOR POLYCYSTIC OVARY SYNDROME (PCOS) IN MEDITERRANEAN AREA.

Z Douma1, C Lautier2, S Haydar2, T Mahjoub1, F Grigorescu2,3.   

Abstract

Genome Wide Association Studies (GWAS) are excellent opportunities to define culprit genes in complex disorders such as the polycystic ovary syndrome (PCOS). PCOS is a prevalent disorder characterized by anovulation, hyperandrogenism and polycystic ovaries, which benefitted from several GWASs in Asians and Europeans revealing more than 20 potential culprit genes near associated single nucleotide variations (SNV). Translation of these findings into the clinical practice raises difficulties since positive hits are surrogate SNVs linked with causative mutations by linkage disequilibrium (LD). Studies in Mediterranean populations (e.g. Southern Europe and North Africa) raise supplementary problems because of a different LD-pattern, which may disrupt the link with causative mutations. Our experience in MEDIGENE program between Tunisia and France enforces the necessity of genetic anthropology studies before translating GWAS data. Tunisians are a heterogeneous population with ancestral Berbers, European, Arab and Sub-Saharan African components while South Europeans display a high level of genetic diversity, partially explained by gene flow from North Africa. Human diversity studies require sampling from Middle East and North Africa (MENA) region that will help to understand genetic factors in complex diseases. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Genome Wide Association Studies; Maghreb; admixture; evolution; polycystic ovary syndrome; population genetics; single nucleotide variations

Year:  2019        PMID: 32010357      PMCID: PMC6992411          DOI: 10.4183/aeb.2019.364

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  38 in total

1.  Ethnic-specific polycystic ovary syndrome: epidemiology, significance and implications.

Authors:  Chandrika N Wijeyaratne; S A Dilini Udayangani; Adam H Balen
Journal:  Expert Rev Endocrinol Metab       Date:  2013-01

2.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Authors:  Zi-Jiang Chen; Han Zhao; Lin He; Yuhua Shi; Yingying Qin; Yongyong Shi; Zhiqiang Li; Li You; Junli Zhao; Jiayin Liu; Xiaoyan Liang; Xiaoming Zhao; Junzhao Zhao; Yingpu Sun; Bo Zhang; Hong Jiang; Dongni Zhao; Yuehong Bian; Xuan Gao; Ling Geng; Yiran Li; Dongyi Zhu; Xiuqin Sun; Jin-E Xu; Cuifang Hao; Chun-E Ren; Yajie Zhang; Shiling Chen; Wei Zhang; Aijun Yang; Junhao Yan; Yuan Li; Jinlong Ma; Yueran Zhao
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

3.  Reproductive outcome in European and Middle Eastern/North African patients.

Authors:  Michael Feichtinger; Christian Göbl; Andrea Weghofer; Wilfried Feichtinger
Journal:  Reprod Biomed Online       Date:  2016-09-20       Impact factor: 3.828

Review 4.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

6.  Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.

Authors:  Assila Ben Salem; Redha Attaoua; Nabil Mtiraoui; Sana Belkahla; Intissar Ezzidi; Mounir Ajina; Moncef Souissi; Patrick Poucheret; Madalina Vintila; Florin Grigorescu; Touhami Mahjoub
Journal:  Mol Biol Rep       Date:  2014-07-04       Impact factor: 2.316

7.  Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.

Authors:  A Dunaif; L Sorbara; R Delson; G Green
Journal:  Diabetes       Date:  1993-10       Impact factor: 9.461

Review 8.  Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity.

Authors:  Wendy M Wolf; Rachel A Wattick; Olivia N Kinkade; Melissa D Olfert
Journal:  Int J Environ Res Public Health       Date:  2018-11-20       Impact factor: 3.390

9.  Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

Authors:  Felix Day; Tugce Karaderi; Michelle R Jones; Cindy Meun; Chunyan He; Alex Drong; Peter Kraft; Nan Lin; Hongyan Huang; Linda Broer; Reedik Magi; Richa Saxena; Triin Laisk; Margrit Urbanek; M Geoffrey Hayes; Gudmar Thorleifsson; Juan Fernandez-Tajes; Anubha Mahajan; Benjamin H Mullin; Bronwyn G A Stuckey; Timothy D Spector; Scott G Wilson; Mark O Goodarzi; Lea Davis; Barbara Obermayer-Pietsch; André G Uitterlinden; Verneri Anttila; Benjamin M Neale; Marjo-Riitta Jarvelin; Bart Fauser; Irina Kowalska; Jenny A Visser; Marianne Andersen; Ken Ong; Elisabet Stener-Victorin; David Ehrmann; Richard S Legro; Andres Salumets; Mark I McCarthy; Laure Morin-Papunen; Unnur Thorsteinsdottir; Kari Stefansson; Unnur Styrkarsdottir; John R B Perry; Andrea Dunaif; Joop Laven; Steve Franks; Cecilia M Lindgren; Corrine K Welt
Journal:  PLoS Genet       Date:  2018-12-19       Impact factor: 6.020

10.  Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Authors:  Sara Haydar; Florin Grigorescu; Mădălina Vintilă; Yannick Cogne; Corinne Lautier; Yildiz Tutuncu; Jean Frederic Brun; Jean Marie Robine; Michel Pugeat; Christophe Normand; Patrick Poucheret; Monica Livia Gheorghiu; Carmen Georgescu; Corin Badiu; Nicoleta Băculescu; Eric Renard; Dorina Ylli; Stephanie Badiou; Thibault Sutra; Jean Paul Cristol; Jacques Mercier; Ramon Gomis; Josep Maria Macias; Serghey Litvinov; Elza Khusnutdinova; Catalina Poiana; Renato Pasquali; Davide Lauro; Giorgio Sesti; Sabrina Prudente; Vincenzo Trischitta; Agathocles Tsatsoulis; Sonia Abdelhak; Abdelhamid Barakat; Akila Zenati; Agron Ylli; Ilhan Satman; Timo Kanninen; Yves Rinato; Sasa Missoni
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.752

View more
  2 in total

1.  Importance of Dehydroepiandrosterone Sulfate Assessment with Special Attention for Adrenal Tumours and Arterial Hypertension.

Authors:  V Matulevicius; V Urbanavicius; S Lukosevicius; I Banisauskaite; G Donielaite; A Galkine
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

2.  The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Chuan Xing; Han Zhao; Jiaqi Zhang; Bing He
Journal:  Front Physiol       Date:  2022-05-09       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.